Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PeiTu QingXin Granules in pediatric atopic dermatitis (heart fire and spleen deficiency pattern) – randomized double-blind phase IIb trial
CTR20232839Phase 2Active
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Pei Tu Qing Xin in atopic dermatitis (AD), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Started Dec 2023; status: active.
02
Drugs
Pei Tu Qing Xin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20232839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232839.